FindTrial
Sign In

Effects of glycine supplementationon on the metabolism of nonalcoholic fatty liver disease

Effect of glycine supplementation on glucose and lipid metabolism in patients with nonalcoholic fatty liver disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046915
Enrollment
Unknown
Registered
2021-05-30
Start date
2021-05-31
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver disease

Interventions

Group 1:glycine
Group 2:maltose

Sponsors

Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Women aged 35-65 with moderate nonalcoholic fatty liver disease.

Exclusion criteria

Exclusion criteria: 1. Patients with hepatitis and other types of liver diseases; 2. Women with drinking habits; 3. Pregnancy; 4. Mental disorders; 5. Tumor; 6. Infectious diseases.

Design outcomes

Primary

MeasureTime frame
hepatic lipid contents;—

Secondary

MeasureTime frame
waist circumference;fast blood glucose;blood pressure;blood lipids;2h-postload glucose;body mass index;—

Countries

China

Contacts

Public ContactFeng Rennan

Harbin Medical University

fengrennan@163.com+86 15945667279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026